Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection
ASSAY and Drug Development Technologies · 2024
DOI: 10.1089/adt.2023.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2024. Verfasst von Gurmeet Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, Punjab, India. Hauptthemen laut MEDLINE: Candida albicans, Antifungal Agents, Imidazoles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, Punjab, India.
- Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India.
ORCID-Profile: Gurmeet Singh
Zitieren
APA
Singh, G., & Narang, R. K. (2024). Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection. ASSAY and Drug Development Technologies. https://doi.org/10.1089/adt.2023.059
Vancouver
Singh G, Narang RK. Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection. ASSAY and Drug Development Technologies. 2024. doi:10.1089/adt.2023.059
BibTeX
@article{Singh2024,
author = {Singh, Gurmeet and Narang, Raj Kumar},
title = {Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection},
journal = {ASSAY and Drug Development Technologies},
year = {2024},
doi = {10.1089/adt.2023.059}
}
EUVIMED